Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 11, 2010
Virtual tour of Eurogentec's diagnostic cGMP oligonucleotide manufacturing facility in Liege, Belgium
Liege, Belgium. Eurogentec S.A. ("Eurogentec") announced that a virtual tour of its diagnostic cGMP oligonucleotide manufacturing facility in Liege, Belgium is now available on its website at http://www.eurogentec.com/IVDvirtualt... The virtual tour allows decision makers in the IVD industry located in any part of the world to easily and quickly pre-audit the first-class clean room facility from their own computer without the need for expensive travel. Each of the classified clean rooms in the facility can be viewed in detail using interactive viewing features.
"The virtual tour provides decision makers evaluating Eurogentec as a potential supplier of custom-synthesized IVD oligonucleotides, an easy and innovative tool to pre-audit our GMP/QSR manufacturing facility and get a great impression of the extraordinary measures we have taken to minimize the risk of contamination," says Dr. Peter Haima, Eurogentec's Director for Diagnostic Services. "In June this year, we also plan to obtain ISO13485 certification of our GMP/QSR compliant clean room oligo production facility in North America'. With this certification of its US site, Eurogentec's strategic plan for having fully harmonized ISO13485-certified facilities in Europe, North America and Asia will be completed. Together, our harmonized global network of manufacturing facilities ensures our diagnostic clients an uninterrupted supply of cGMP-grade oligos."
About Eurogentec Eurogentec is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. Eurogentec S.A. provides a wide range of expertise in small- and large-scale DNA, RNA, peptide synthesis and antibody supply. Eurogentec is also an experienced contract manufacturing organization (CMO), operating a state-of-the-art GMP/QSR compliant and ISO13485:2003 certified oligonucleotide manufacturing facility in Belgium. The Belgium manufacturing facility for IVD oligos is complemented by additional production facilities in North America and Asia (Japan). The North American facility is on schedule to be ISO13485 certified and fully GMP/QSR compliant by June 2010. Eurogentec is also an experienced CMO for biopharmaceuticals, operating a full-service, state-of-the-art GMP facility in Belgium.